Trials: Gastrointestinal Cancer

Disease sites included: Colon, Rectal, Liver, Stomach Pancreatic, Esophageal, Anal, Small Intestine, Gallbladder, Bile Duct

You are here:

Find a Clinical Trial
Gastrointestinal Cancer

NCT02598349 – PAN009-18 A Phase II Trial of Escalated Dose Proton Radiotherapy with Elective Nodal Irradiation and Concomitant Chemotherapy for Patients with Unresectable, Borderline Resectable or Medically Inoperable Pancreatic Adenocarcinoma

August 13, 2026

NCT04239573 – EA2185: Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs

June 10, 2026

NCT05174169 – NRG-GI008: Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-NORTH AMERICA)

June 10, 2026

NCT06203600 – S2303, Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel +Ramucirumab versus Paclitaxel + Ramucirumab in Patients with PD-L1 CPS = 1Advanced Gastric and Esophageal Adenocarcinoma (PARAMUNE)

June 10, 2026

NCT07539155 – Phase Ib/II Study of Intratumoral MMR vaccine injection in borderline resectable/unresectable pancreatic cancer

July 14, 2026

NCT07573215 – Expanded Access Program to Treat Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma with Daraxonrasib

August 13, 2026